Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KSEP
4001
Innovator U.S. Small Cap Power Buffer ETF - September
KSEP
$38.3M
| $502K | ﹤0.01% |
19,633
-3,440
| -15% | -$84.8K |
2024 Q4
2 quarters
|
|
4002
iShares US Oil Equipment & Services ETF
IEZ
$346M
| $501K | ﹤0.01% |
29,545
-6,520
| -18% | -$109K |
2024 Q4
2 quarters
|
|
|
QIG
4003
WisdomTree U.S. Corporate Bond Fund
QIG
$16.8M
| $501K | ﹤0.01% |
11,212
+935
| +9% | +$41.1K |
2024 Q4
2 quarters
|
|
|
CEV
4004
Eaton Vance California Municipal Income Trust
CEV
$72.2M
| $500K | ﹤0.01% |
51,580
+3,606
| +8% | +$34.9K |
2024 Q4
2 quarters
|
|
4005
Fidelity Limited Term Bond ETF
FLTB
$476M
| $499K | ﹤0.01% |
9,905
+438
| +5% | +$21.9K |
2024 Q4
2 quarters
|
|
4006
Corvus Pharmaceuticals
CRVS
$919M
| $498K | ﹤0.01% |
124,496
+16,379
| +15% | +$59.6K |
2024 Q4
2 quarters
|
|
4007
MarineMax
HZO
$1.16B
| $498K | ﹤0.01% |
19,806
-90
| -0.5% | -$1.99K |
2024 Q4
2 quarters
|
|
4008
Star Bulk Carriers
SBLK
$3.53B
| $497K | ﹤0.01% |
28,797
-36,658
| -56% | -$570K |
2024 Q4
2 quarters
|
|
4009
Pathward Financial
CASH
$1.53B
| $496K | ﹤0.01% |
+6,265
| New | +$479K |
2025 Q2
0 quarters
|
|
|
CALY
4010
Callaway Golf Company
CALY
$2.56B
| $495K | ﹤0.01% |
61,447
+12,084
| +24% | +$83.1K |
2024 Q4
2 quarters
|
|
|
EAD
4011
Allspring Income Opportunities Fund
EAD
$355M
| $494K | ﹤0.01% |
69,939
-5,600
| -7% | -$37.7K |
2024 Q4
2 quarters
|
|
|
MXF
4012
Mexico Fund
MXF
$287M
| $494K | ﹤0.01% |
28,090
-6,807
| -20% | -$109K |
2024 Q4
2 quarters
|
|
|
IAS
4013
DELISTED
Integral Ad Science
IAS
| $493K | ﹤0.01% |
59,310
-8,863
| -13% | -$67.6K |
2024 Q4
2 quarters
|
|
4014
Nuveen ESG International Developed Markets Equity ETF
NUDM
$726M
| $493K | ﹤0.01% |
13,879
-6,343
| -31% | -$212K |
2024 Q4
2 quarters
|
|
4015
Touchstone Dynamic International ETF
TDI
$464M
| $493K | ﹤0.01% |
14,489
-2,888
| -17% | -$90.6K |
2025 Q1
1 quarter
|
|
4016
TPG
TPG
$7.46B
| $491K | ﹤0.01% |
9,365
-5,295
| -36% | -$254K |
2024 Q4
2 quarters
|
|
4017
Range Nuclear Renaissance Index ETF
NUKZ
$693M
| $491K | ﹤0.01% |
+8,677
| New | +$399K |
2025 Q2
0 quarters
|
|
4018
Dyne Therapeutics
DYN
$2.95B
| $490K | ﹤0.01% |
51,480
-1,613
| -3% | -$17.8K |
2024 Q4
2 quarters
|
|
4019
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$108M
| $490K | ﹤0.01% |
41,665
+8,352
| +25% | +$98.3K |
2024 Q4
2 quarters
|
|
4020
Franklin Covey
FC
$197M
| $488K | ﹤0.01% |
+21,395
| New | +$473K |
2025 Q2
0 quarters
|
|
4021
VanEck Environmental Services ETF
EVX
$94.5M
| $486K | ﹤0.01% |
12,704
+158
| +1% | +$5.73K |
2024 Q4
2 quarters
|
|
|
SVM
4022
Silvercorp Metals
SVM
$2.35B
| $486K | ﹤0.01% |
115,208
+80,835
| +235% | +$313K |
2024 Q4
2 quarters
|
|
4023
BNY Mellon US Large Cap Core Equity ETF
BKLC
$5.82B
| $486K | ﹤0.01% |
12,315
+411
| +3% | +$15K |
2024 Q4
2 quarters
|
|
|
FT
4024
Franklin Universal Trust
FT
$177M
| $486K | ﹤0.01% |
63,780
+1,455
| +2% | +$10.8K |
2024 Q4
2 quarters
|
|
4025
AllianzIM U.S. Equity Buffer10 Aug ETF
AUGT
$35.3M
| $486K | ﹤0.01% |
14,794
| – | – |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.